Intellectual property rights: Big pharma makes billions from vaccine apartheid
By Cathal Curran In the month since the discovery of the Omicron variant, it has already spread across the globe, brought about the return of harsh restrictions on the lives of millions, and made shareholders in vaccine manufacturers billions. In the first
